12 Health Care Stocks Witness Significant Movement in Tuesday's After-Market Session

Healthcare stocks saw significant movements in Tuesday's after-market session. Gainers included Innovative Eyewear, Apyx Medical, Xilio Therapeutics, Omeros, Hims & Hers Health, and Agape ATP, while losers were Polyrizon, Accelerate Diagnostics, Regencell Bioscience, Halozyme Therapeutics, Kindly MD, and Vivani Medical.

Healthcare stocks experienced significant fluctuations in Tuesday's after-market session. Gainers included Innovative Eyewear (LUCY), Apyx Medical (APYX), Xilio Therapeutics (XLO), Omeros (OMER), Hims & Hers Health (HIMS), and Agape ATP (ATPC). Meanwhile, losers were Polyrizon (PLRZ), Accelerate Diagnostics (AXDX), Regencell Bioscience (RGC), Halozyme Therapeutics (HALO), Kindly MD (KDLY), and Vivani Medical (VANI).

Gainers:

- Innovative Eyewear (LUCY): The stock increased by 57.2% to $2.94, with a market value of $8.9 million. The company reported its Q1 2025 unaudited financial results, showing revenue growth and margin improvements. Revenue reached $454,501, up 19% from Q1 2024, driven by new product launches including Nautica® and Eddie Bauer® collections. Gross profit margin significantly improved to 49% from 2% in Q1 2024. Despite these improvements, the company reported a net loss of $1,778,703, though smaller than Q1 2024's loss of $1,971,311 [3].

- Apyx Medical (APYX): The stock rose 42.98% to $1.58, with a market value of $59.7 million. The company's Q1 earnings came out 3 days ago [2].

- Xilio Therapeutics (XLO): The stock moved upwards by 40.9% to $1.03, with a market cap of $53.3 million. The company's Q1 earnings also came out 3 days ago [2].

- Omeros (OMER): The stock increased by 16.2% to $4.41, with a market cap of $255.5 million [2].

- Hims & Hers Health (HIMS): The stock moved upwards by 15.92% to $64.0, with a market value of $14.3 billion [2].

- Agape ATP (ATPC): The stock increased by 15.15% to $1.9, with a market cap of $95.0 million [2].

Losers:

- Polyrizon (PLRZ): The stock declined by 95.5% to $0.02 during Tuesday's after-market session [2].

- Accelerate Diagnostics (AXDX): The stock fell 44.08% to $0.07, with a market cap of $1.8 million [2].

- Regencell Bioscience (RGC): The stock decreased by 36.9% to $296.59, with a market cap of $3.8 billion [2].

- Halozyme Therapeutics (HALO): The stock fell 24.91% to $50.0, with a market value of $6.1 billion [2].

- Kindly MD (KDLY): The stock declined by 23.96% to $10.41, with a market value of $62.2 million. The company's Q1 earnings came out 3 days ago [2].

- Vivani Medical (VANI): The stock decreased by 20.39% to $0.82, with a market cap of $54.6 million. The company's Q1 earnings came out today [2].

These movements reflect the ongoing volatility in the healthcare sector, driven by various factors including earnings reports, market sentiment, and geopolitical events. Investors should continue to monitor these companies for further developments.

References:

[1] https://www.cnbc.com/2025/05/13/1-stock-we-just-initiated-and-3-others-get-nice-bumps-after-saudis-us-spending-spree.html

[2] https://www.benzinga.com/insights/movers/25/05/45392931/12-health-care-stocks-moving-in-tuesdays-after-market-session

[3] https://www.stocktitan.net/news/LUCY/innovative-eyewear-inc-reports-q1-2025-unaudited-financial-ufmaqq8mocwd.html